Current reports

3/2024 Medicalgorithmics US Holding will receive $0.66 million from React Group as a sale price adjustment for Medi-Lynx

2/2024 Dates of publication of periodic reports in 2024

1/2024 Information on registration of amendment to the Company’s Articles ofAssociation

36/2023 List of Shareholders Holding at Least 5% of Votes in the Total Number of Votes at the Extraordinary General Meeting of Medicalgorithmics S.A. on December 19, 2023

35/2023 Resolutions of the Extraordinary General Meeting of Medicalgorithmics S.A., which took place on December 19, 2023

3/2024 Medicalgorithmics US Holding will receive $0.66 million from React Group as a sale price adjustment for Medi-Lynx

2/2024 Dates of publication of periodic reports in 2024

1/2024 Information on registration of amendment to the Company’s Articles ofAssociation

26/2023 Information on Adjustments in Consolidated Comparable Data for 2022 of the Medicalgorithmics S.A. Capital Group

24/2023 Information on changes in the structure of the Issuer’s international sales leadership team

23/2023 Information on the conclusion by Medicalgorithmics S.A. with its registered office in Warsaw of a public procurement agreement for the supply of devices

22/2023 Medicalgorithmics subsidiary Kardiolytics’ receives two new European patents for computerized segmentation of contrast-filled coronary vessels using computed tomography imaging and a medical imaging system and method supported by technology for coronary segmentation22/2023

21/2023 Information on the intention of Medicalgorithmics S.A. with its registered office in Warsaw to conclude a public procurement contract in connection with the selection of the Company’s offer as the most advantageous in the public procurement procedure

72/2022 Making a decision to adopt a strategy for the US market.

73/2022 Appointment of a Member of the Management Board of Medicalgorithmics S.A.

74/2022 Notification received from Powszechne Towarzystwo Emerytalne PZU S.A. on the reduction of the number of votes held by Otwarty Fundusz Emerytalny PZU „Złota Jesień” at the General Meeting of Medicalgorithmics S.A.

71/2022 Notification received from Miri Capital Management LLC on the reduction of the number of votes held by The Miri Strategic Emerging Markets Fund LP at the General Meeting of Medicalgorithmics S.A.

69/2022 Notification received from Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. on reducing the number of votes held at the General Meeting of Medicalgorithmics S.A.

58/2021 Notification of a Shareholder on a change in a share in the share capital and in the total number of votes in the Company

57/2021 Notification of a Shareholder on a change in a share in the share capital and in the total number of votes in the Company

55/2021 Receipt of aid funds in the amount of USD 1.9 million (PLN 7.8 million) by a subsidiary of the Issuer

54/2021 Registration of the share capital increase

53/2021 Information on the number of payment requests from insurers submitted in November 2021

47/2020 Conclusion by the Issuer’s subsidiary of an agreement for the purchase of 25% of units in Medi-Lynx and setting forth the conditions for payment of a promissory note

46/2020 Information on the number of payment requests from insurers submitted in November 2020

45/2020 Disbursement of the loan taken by the Company from Bank Millenium S.A.

44/2020 Information on the number of payment requests from insurers submitted in October 2020

43/2020 Conclusion of a significant contract by a subsidiary

43/2019 Information on the number of payment requests from insurers submitted in November 2019

41/2019 Announcement on convening the Extraordinary General Meeting of Medicalgorithmics S.A.

42/2019 Contents of draft resolutions for the Extraordinary General Meeting of Medicalgorithmics S.A. convened for 7 January 2020

40/2019 Decisions made in the course of the strategic options review

39/2019 Information on the number of payment requests from insurers submitted in October 2019

39/2018 Information on the number of payment requests from insurers submitted in November 2018

38/2018 Receipt of notification from a shareholder under Article 69 of the Act on Public Offering

37/2018 Information on the number of payment requests from insurers submitted in October 2018

36/2018 Appointment of CEO of Medi-Lynx Cardiac Monitoring, LLC

35/2018 Information on the number of payment requests from insurers submitted in September 2018

36/2017 Conclusion of a co-financing agreement with the National Centre for Research and Development

35/2017 Information on the number of payment requests from insurers submitted by Medi-Lynx Cardiac Monitoring, LLC in November 2017

34/2017 Registration of amendments to the Articles of Association of Medicalgorithmics S.A.

33/2017 Receipt of notification from a shareholder under Article 69 of the Act on Public Offering

32/2017 Information on the number of payment requests from insurers submitted by Medi-Lynx Cardiac Monitoring, LLC in October 2017

Your submission was succesfull

Software

Get more information
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

VCAST

Get a free demo
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

DRAI

Get a free demo
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

Our company

About us

Our History

Management Team

Partners

Career

Work with us

Job offers

Recommend an employee

Application form